DNA immunization technology is based on the availability of adequate vector
s for cloning and expression of heterologous immunoactive proteins in mamma
lian cells. We have developed a family of DNA plasmid vectors suitable to m
anipulate antigen expression and location. Their in vitro and in vivo funct
ionality and application are also reported. The developed immune response,
the aspects considered for vector design, and the possible independent mani
pulation of both blocks for the generation of bicistronic constructs, make
of the pAEC family of plasmid vectors a source for DNA vaccine candidate's
development for further evaluation in human clinical trials, and for potent
ial use in the gene therapy approach. (C) 2000 Academic Press.